Lumos Diagnostics Holdings Limited (LDXHF)

USD 0.02

(0.0%)

Total Liabilities Summary of Lumos Diagnostics Holdings Limited

  • Lumos Diagnostics Holdings Limited's latest annual total liabilities in 2024 was 19.72 Million USD , up 23.85% from previous year.
  • Lumos Diagnostics Holdings Limited's latest quarterly total liabilities in 2024 FY was 19.69 Million USD , up 23.62% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported annual total liabilities of 15.92 Million USD in 2023, down -16.4% from previous year.
  • Lumos Diagnostics Holdings Limited reported annual total liabilities of 19.05 Million USD in 2022, down -52.01% from previous year.
  • Lumos Diagnostics Holdings Limited reported quarterly total liabilities of 19.72 Million USD for 2024 Q4, down 0.0% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported quarterly total liabilities of 19.69 Million USD for 2024 FY, up 23.62% from previous quarter.

Annual Total Liabilities Chart of Lumos Diagnostics Holdings Limited (2024 - 2018)

Created with Highcharts 11.1.0YearsTotal Liabilities20182019202020212022202320240 USD10000000 USD20000000 USD30000000 USD40000000 USD50000000 USD

Historical Annual Total Liabilities of Lumos Diagnostics Holdings Limited (2024 - 2018)

Year Total Liabilities Total Liabilities Growth
2024 19.72 Million USD 23.85%
2023 15.92 Million USD -16.4%
2022 19.05 Million USD -52.01%
2021 39.7 Million USD 389.97%
2020 8.1 Million USD -41.01%
2019 13.73 Million USD 132.74%
2018 5.9 Million USD 0.0%

Peer Total Liabilities Comparison of Lumos Diagnostics Holdings Limited

Name Total Liabilities Total Liabilities Difference
American Bio Medica Corporation 3.6 Million USD -446.813%
Arrayit Corporation 7.49 Million USD -163.173%
Atlantic International Corp. 3.82 Million USD -415.303%
Biocept, Inc. 22.01 Million USD 10.376%
Bioqual, Inc. 18.93 Million USD -4.177%
CardioGenics Holdings Inc 1.79 Million USD -999.156%
DermTech, Inc. 64.75 Million USD 69.533%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 734.97 Million USD 97.316%
HTG Molecular Diagnostics, Inc. 12.38 Million USD -59.285%
iMD Companies, Inc. 1.67 Million USD -1078.402%
IDenta Corp. 1.01 Million USD -1847.278%
Interpace Biosciences, Inc. 28.15 Million USD 29.932%
Integrative Health Technologies, Inc. 297.94 Thousand USD -6521.647%
InVitro International 78.99 Thousand USD -24876.578%
Many Bright Ideas Technologies Inc. 129.29 Thousand USD -15158.667%
Medical Imaging Corp. 9.51 Million USD -107.301%
NovelStem International Corp. 4.2 Million USD -369.059%
Optigenex Inc. 9.57 Million USD -106.141%
PharmChem, Inc. 558.64 Thousand USD -3431.568%
Proteome Sciences plc 18.48 Million USD -6.706%
Response Genetics, Inc 15.86 Million USD -24.34%
Rennova Health, Inc. 49.66 Million USD 60.278%
RushNet, Inc. 6.23 Million USD -216.221%
ScreenPro Security Inc. 1.6 Million USD -1132.61%
Stella Diagnostics Inc. 18 Million USD -9.573%
StageZero Life Sciences Ltd. 8.2 Million USD -140.481%
Todos Medical Ltd. 50.15 Million USD 60.666%